Stock AYTU AYTU BIOSCIENCE INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Aytu Bioscience Inc OTC Bulletin Board

Equities

AYTU

US0547542052

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Aytu Bioscience Inc
05-15 Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024
05-15 Aytu BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI

Chart calendar Aytu Bioscience Inc

3ee6c2acd503290283aa27.NQ_bbMw4a0Dp7JOAmrBelDRTQ6Yf3H_zQfP2Mqk6cDg.YmexGYYOLxSa3qXY3YAa02USE-p3r0eEEougftN1GnVeObQhu1JTDbPaxg~47db4aebc127d27cb9fad1928adf5c58

Upcoming events on Aytu Bioscience Inc

2024-06-26 12:00 Annual General Meeting
2024-09-24 Q4 2024 Earnings Release (Projected)
2024-11-13 Q1 2025 Earnings Release (Projected)
2025-02-11 Q2 2025 Earnings Release (Projected)
2025-05-18 Q3 2025 Earnings Release (Projected)

Past events on Aytu Bioscience Inc

2024-05-30 13:15 Lytham Partners Spring Investor Conference
2024-05-15 16:30 Q3 2024 Earnings Call
2024-05-14 Q3 2024 Earnings Release After hours
2024-04-04 16:40 Emerging Growth Conference
2024-02-14 16:30 Q2 2024 Earnings Call
2024-02-14 16:05 Q2 2024 Earnings Release
2024-02-01 11:45 Lytham Partners Investor Select Conference
2023-12-07 13:10 Emerging Growth Conference
2023-11-14 16:30 Q1 2024 Earnings Call
2023-11-14 16:05 Q1 2024 Earnings Release
2023-10-17 07:00 Lytham Partners Fall Investor Conference
2023-10-04 13:00 LD Micro Main Event Conference
2023-09-27 16:30 Q4 2023 Earnings Call
2023-09-27 16:20 Q4 2023 Earnings Release
2023-06-21 15:00 Maxim Group Virtual Healthcare Conference
2023-05-18 12:00 Annual General Meeting
2023-05-11 16:30 Q3 2023 Earnings Call
2023-05-11 16:05 Q3 2023 Earnings Release
2023-02-21 17:00 Interim 2023 Earnings Call
2023-02-21 16:10 Interim 2023 Earnings Release

Annual results

Fiscal PeriodJuni 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		7,32
7,38
-0.77%		27,6
24,0
15.01%		65,6
66,2
-0.78%		96,7
94,7
2.08%		107
104
2.91%
81,3

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-46,8
-21,8
-114.45%		-25,9
-68,3
62.15%		-4,94
-4,35
-13.64%
9,18

EBIT
Million USD		Released
Forecast
Spread 		-16,8
-16,7
-0.98%		-20,9
-18,1
-15.89%		-58,9
-45,5
-29.38%		-112
-105
-6.1%		-12,3
-20,4
39.62%
-2,83

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-27,1
-16,9
-60.57%		-13,6
-17,1
20.18%		-58,0
-50,4
-15.25%		-110
-105
-5.38%		-17,1
-20,7
17.44%
-12,7

Net income
Million USD		Released
Forecast
Spread 		-27,1
-17,1
-59.06%		-13,6
-15,1
9.53%		-58,3
-50,4
-15.77%		-110
-105
-5.38%		-17,1
-20,7
17.44%
-13,7

EPS
USD		Released
Forecast
Spread 		-696
-430
-61.86%		-60,0
-44,0
-36.36%		-69,6
-56,8
-22.54%		-75,0
-71,5
-4.9%		-5,11
-6,16
17.05%
-2,49

Announcement Date26/09/1906/10/2027/09/2127/09/2227/09/23-

Quarterly results

Fiscal PeriodJuni 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		24,2
24,5
-1.23%		27,4
25,5
7.64%		27,7
24,3
13.81%		26,3
29,5
-10.92%		22,7
27,6
-17.48%		30,7
27,7
10.97%		22,1
27,7
-20.3%		22,9
21,7
5.47%		18,0
17,3
3.73%
18,3

EBITDA
Million USD		Released
Forecast
Spread 		-6,81
-7,50
9.2%		-4,86
-4,00
-21.45%


-2,02
4,60
-143.83%		-6,36
1,20
-630.33%		4,65
0,09
4948.91%		0,44
1,65
-73.52%		5,08
0,35
1352.29%		0,43
0,50
-14.14%
1,46

EBIT
Million USD		Released
Forecast
Spread 		-54,7
-11,3
-385.82%		-17,9
-11,5
-55.77%		-1,65
-9,00
81.63%		-4,19
-1,70
-146.65%		-8,56
-2,20
-289%		2,81
-2,68
204.81%		-1,50
1,05
-243.92%		2,36
-0,09
2726.67%		-2,46
-2,26
-9.03%
-1,23

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-53,1
-11,9
-347.87%		-17,7
-12,1
-46.29%		-2,88
-9,40
69.35%		-6,69
-2,00
-234.65%		-7,20
-2,55
-182.35%		-2,46
-3,88
36.68%		-8,12
-0,24
-3340.68%		0,61
-1,37
144.35%		-2,64
-3,54
25.39%
-2,51

Net income
Million USD		Released
Forecast
Spread 		-53,1
-11,9
-347.87%		-17,7
-12,1
-46.29%		-2,88
-9,40
69.35%		-6,69
-2,10
-218.71%		-7,20
-2,55
-182.35%		-2,46
-3,88
36.68%		-8,12
-0,24
-3340.68%		-0,22
-1,37
83.95%		-2,89
-3,54
18.47%
-2,51

EPS
USD		Released
Forecast
Spread 		-35,8
-8,20
-336.59%		-7,00
-7,40
5.41%		-1,20
-3,60
66.67%		-2,15
-0,70
-207.14%		-1,93
-0,72
-169.93%		-0,59
-0,95
37.89%		-1,48
-0,04
-3600%		-0,04
-0,25
84%		-0,52
-0,64
18.75%
-0,45

Announcement Date16/05/2227/09/2214/11/2221/02/2311/05/2327/09/2314/11/2314/02/2415/05/24-

Upcoming sector events for Aytu Bioscience Inc

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 06:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Aytu Bioscience Inc

2024-06-07 06:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
2024-06-07 05:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
2024-05-30 08:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
2024-05-29 04:44 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-29 04:10 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-28 PFIZER LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. AYTU Stock
  4. AYTU Stock
  5. Calendar Aytu Bioscience Inc